These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 29744951)
41. Effects of IL-32 polymorphisms and IL-32 levels on the susceptibility and severity of coronary artery disease. Jin S; Liu X; Wang Y; Yu J; Jiang M J Clin Lab Anal; 2022 Jan; 36(1):e24114. PubMed ID: 34799941 [TBL] [Abstract][Full Text] [Related]
42. Clinical value of BRE-AS1 in myocardial infarction and its role in myocardial infarction-induced cardiac muscle cell apoptosis. Gao Z; Zhu H; Chen J; Liu W; Huo J; He C; Chen J Scand Cardiovasc J; 2024 Dec; 58(1):2347290. PubMed ID: 38733316 [No Abstract] [Full Text] [Related]
43. Proinflammatory cytokine IFN-γ, lncRNA BANCR and the occurrence of coronary artery disease. Wang H; Zhang N; Li G; Xu B Life Sci; 2019 Aug; 231():116510. PubMed ID: 31141710 [TBL] [Abstract][Full Text] [Related]
44. Correlation of pre-operative circulating inflammatory cytokines with restenosis and rapid angiographic stenotic progression risk in coronary artery disease patients underwent percutaneous coronary intervention with drug-eluting stents. Sun J; Yu H; Liu H; Pu D; Gao J; Jin X; Liu X; Yan A J Clin Lab Anal; 2020 Mar; 34(3):e23108. PubMed ID: 31729103 [TBL] [Abstract][Full Text] [Related]
45. Effects of IFNG-AS1 and ANRIL on intestinal epithelial cells and their relationship with colitis. Huang Q; Shi CM; Miao YL; Chen Y Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7345-7356. PubMed ID: 32706073 [TBL] [Abstract][Full Text] [Related]
46. Serum cytokine tumor necrosis factor-alpha and interleukin-6 associated with the severity of coronary artery disease: indicators of an active inflammatory burden? Gotsman I; Stabholz A; Planer D; Pugatsch T; Lapidus L; Novikov Y; Masrawa S; Soskolne A; Lotan C Isr Med Assoc J; 2008 Jul; 10(7):494-8. PubMed ID: 18751625 [TBL] [Abstract][Full Text] [Related]
47. Plasma Long Non-Coding RNA (lncRNA) GAS5 is a New Biomarker for Coronary Artery Disease. Yin Q; Wu A; Liu M Med Sci Monit; 2017 Dec; 23():6042-6048. PubMed ID: 29267258 [TBL] [Abstract][Full Text] [Related]
48. LncRNA ANRIL/miR-125a axis exhibits potential as a biomarker for disease exacerbation, severity, and inflammation in bronchial asthma. Ye S; Zhu S; Feng L J Clin Lab Anal; 2020 Mar; 34(3):e23092. PubMed ID: 31821602 [TBL] [Abstract][Full Text] [Related]
49. Expression of lncRNA-ANRIL in patients with coronary heart disease before and after treatment and its short-term prognosis predictive value. Liu ZF; Hu WW; Li R; Gao Y; Yan LL; Su N Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):376-384. PubMed ID: 31957852 [TBL] [Abstract][Full Text] [Related]
50. Variation in high-sensitivity C-reactive protein levels over 24 hours in patients with stable coronary artery disease. Koc M; Karaarslan O; Abali G; Batur MK Tex Heart Inst J; 2010; 37(1):42-8. PubMed ID: 20200626 [TBL] [Abstract][Full Text] [Related]
51. Long non-coding RNA in coronary artery disease: the role of PDXDC1-AS1 and SFI1-AS1. He S; Zhang S; Wang YJ; Gan XK; Chen JX; Zhou HX; Jia EZ Funct Integr Genomics; 2023 Jul; 23(3):219. PubMed ID: 37394483 [TBL] [Abstract][Full Text] [Related]
52. MiR-15a Functions as a Diagnostic Biomarker for Coronary Artery Disease. Pan X; He Y; Ling S; Chen Z; Yan G Clin Lab; 2020 Aug; 66(8):. PubMed ID: 32776741 [TBL] [Abstract][Full Text] [Related]
53. Clinical significance of lncRNA-AWPPH in coronary artery diseases. Tang TT; Wang BQ Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11747-11751. PubMed ID: 33275243 [TBL] [Abstract][Full Text] [Related]
54. The evaluation value of atherogenic index of plasma and high-sensitivity C-reactive protein for the degree of coronary artery lesion in premature coronary artery disease. Song Y; Wang M; Li Y; Lian Y BMC Cardiovasc Disord; 2024 Aug; 24(1):410. PubMed ID: 39107719 [TBL] [Abstract][Full Text] [Related]
55. Assessment of expression of interferon γ (IFN-G) gene and its antisense (IFNG-AS1) in breast cancer. Yaghoobi H; Azizi H; Oskooei VK; Taheri M; Ghafouri-Fard S World J Surg Oncol; 2018 Oct; 16(1):211. PubMed ID: 30336781 [TBL] [Abstract][Full Text] [Related]
56. Serial changes in plasma levels of cytokines in patients with coronary artery disease. Heinisch RH; Zanetti CR; Comin F; Fernandes JL; Ramires JA; Serrano CV Vasc Health Risk Manag; 2005; 1(3):245-50. PubMed ID: 17319110 [TBL] [Abstract][Full Text] [Related]
57. Long noncoding RNA HULC in acute ischemic stroke: Association with disease risk, severity, and recurrence-free survival and relation with IL-6, ICAM1, miR-9, and miR-195. Chen X; Zhang X; Su C; Huang S J Clin Lab Anal; 2020 Nov; 34(11):e23500. PubMed ID: 32815572 [TBL] [Abstract][Full Text] [Related]
58. The clinical value of long noncoding RNA GAS5 in acute ischemic stroke: Correlation with disease risk, inflammation, severity, and risk of recurrence. Fang P; Wu Y; Zhang Z; Cui C; Dong X; Hu K; Jia J; Duan X; Zhang Y; Huo H J Clin Lab Anal; 2022 Jan; 36(1):e24171. PubMed ID: 34921461 [TBL] [Abstract][Full Text] [Related]
59. Lower Expression of miR-10a in Coronary Artery Disease and its Association with Pro/Anti-Inflammatory Cytokines. Moradi N; Fadaei R; Ahmadi R; Kazemian E; Fallah S Clin Lab; 2018 May; 64(5):847-854. PubMed ID: 29739060 [TBL] [Abstract][Full Text] [Related]
60. Inflammatory markers, angiographic severity of coronary artery disease, and patient outcome. Sukhija R; Fahdi I; Garza L; Fink L; Scott M; Aude W; Pacheco R; Bursac Z; Grant A; Mehta JL Am J Cardiol; 2007 Apr; 99(7):879-84. PubMed ID: 17398176 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]